v3.26.3
Financial risk management (Tables)
 6 Months Ended 12 Months Ended
Dec. 31, 2025
Jun. 30, 2025
Financial Risk Management    
Schedule of group’s current credit risk grading framework

The Group’s current credit risk grading framework comprises the following categories:

 

Category   Definition of category  

Basis for recognising

expected credit loss

(ECL)

I   Counterparty has a low risk of default and does not have any past-due amounts.   12-month ECL
II   Amount is >30 days past due or there has been a significant increase in credit risk since initial recognition.   Lifetime ECL - not credit-impaired
III   Amount is >60 days past due or there is evidence indicating the asset is credit-impaired (in default).   Lifetime ECL - credit impaired
IV   There is evidence indicating that the debtor is in severe financial difficulty and the debtor has no realistic prospect of recovery.   Amount is written off

The Group’s current credit risk grading framework comprises the following categories:

 

 

 

Category

  

 

 

Definition of category

  

Basis for recognising

expected credit loss

(ECL)

I   Counterparty has a low risk of default and does not have any past-due amounts.   12-month ECL
II   Amount is >30 days past due or there has been a significant increase in credit risk since initial recognition.   Lifetime ECL - not credit-impaired
III   Amount is >60 days past due or there is evidence indicating the asset is credit-impaired (in default).   Lifetime ECL - credit impaired
IV   There is evidence indicating that the debtor is in severe financial difficulty and the debtor has no realistic prospect of recovery.   Amount is written off
Schedule of financial assets, minimum exposure to credit risk

The table below details the credit quality of the Group’s financial assets, as well as maximum exposure to credit risk by credit risk rating categories:

 

          12-month            
        or  Gross      Net 
          lifetime  carrying   Loss   carrying 
   Note   Category  ECL  amount   allowance   amount 
          US$   US$   US$ 
December 31, 2025                          
Trade receivables   12   Note 1  Lifetime ECL -simplified   2,971,932    (457,557)   2,514,375 
Deposits   12   I  12-month ECL   5,489,917    -    5,489,917 
Other receivables   12   I  12-month ECL   154,162    -    154,162 
                    (457,557)     

 

 

Basel Medical Group Ltd and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the financial period ended December 31, 2025

 

22. Financial risk management (Continued)

 

  a) Credit risk (Continued)

 

          12-month  Gross       Net 
          or lifetime  carrying   Loss   carrying 
   Note   Category  ECL  amount   allowance   amount 
             S$   S$   S$ 
December 31, 2025                          
Trade receivables   12   Note 1  Lifetime ECL -simplified   3,821,607    (588,373)   3,233,234 
Deposits   12   I  12-month ECL   7,105,501    -    7,105,501 
Other receivables   12   I  12-month ECL   198,237    -    198,237 
                    (588,373)     
                           
June 30, 2025 (Audited)                          
Trade receivables   12   Note 1  Lifetime ECL -simplified   2,740,055    (588,373)   2,151,682 
Deposits   12   I  12-month ECL   6,996,631    -    6,996,631 
Other receivables   12   I  12-month ECL   134,188    -    134,188 
                    (588,373)     

The table below details the credit quality of the Group’s financial assets, as well as maximum exposure to credit risk by credit risk rating categories:

 

  

 

 

Note

  

 

 

Category

 

12-month or

lifetime

ECL

 

Gross

carrying

amount

  

 

Loss

allowance

  

Net

carrying

amount

 
             US$   US$   US$ 
June 30, 2025                      
Trade receivables   12   Note 1  Lifetime ECL (simplified)   2,154,300    (462,593)   1,691,707 
Other receivables   12   I  12-month ECL   105,502    -    105,502 
Deposits   12   I  12-month ECL   5,324,813    -    5,324,813 
                    (462,593)     

 

 

Basel Medical Group Ltd. and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

 

25.Financial risk management (Continued)

 

a)Credit risk (Continued)

 

  

 

 

Note

  

 

 

Category

 

12-month or

lifetime

ECL

 

Gross

carrying

amount

  

 

Loss

allowance

  

Net

carrying

amount

 
             S$   S$   S$ 
June 30, 2025                      
Trade receivables   12   Note 1  Lifetime ECL (simplified)   2,740,055    (588,373)   2,151,682 
Other receivables   12   I  12-month ECL   134,188    -    134,188 
Deposits   12   I  12-month ECL   6,772,629    -    6,772,629 
                    (588,373)     
                           
June 30, 2024                          
Trade receivables   12   Note 1  Lifetime ECL (simplified)   2,133,573    (460,413)   1,673,160 
Other receivables   12   I  12-month ECL   213,644    -    213,644 
Deposits   12   I  12-month ECL   90,252    -    90,252 
Amount due from  related parties   14   I  12-month ECL   10,557,240    -    10,557,240 
                    (460,413)     
Schedule of credit risk

 

   due   1 – 60 days   61 – 120 days   > 120 days   > 365 days   Total 
   Trade receivables 
   Days past due 
   Not past                     
   due   1 – 60 days   61 – 120 days   > 120 days   > 365 days   Total 
   US$   US$   US$   US$   US$   US$ 
                         
December 31, 2025                              
ECL rate   7%   11%   22%   26%   26%     
Estimated total gross carrying amount at   693,923    1,130,636    312,436    396,665    438,271    2,971,931 
ECL   (49,180)   (124,348)   (69,443)   (101,929)   (112,656)   (457,556)
                             2,514,375 

 

   due   1 – 60 days   61 – 120 days   > 120 days   > 365 days   Total 
   Trade receivables 
   Days past due 
   Not past                     
   due   1 – 60 days   61 – 120 days   > 120 days   > 365 days   Total 
   S$   S$   S$   S$   S$   S$ 
                         
December 31, 2025                              
ECL rate   7%   11%   22%   26%   26%     
Estimated total gross carrying amount at   892,316    1,453,885    401,761    510,072    563,573    3,821,607 
ECL   (63,241)   (159,899)   (89,297)   (131,071)   (144,865)   (588,373)
                             3,233,234 
                               
June 30, 2025 (Audited)                              
ECL rate   15%   54%   54%   59%   59%     
Estimated total gross carrying amount at   804,724    979,987    244,561    386,405    324,378    2,740,055 
ECL   (116,455)   (174,010)   (68,020)   (135,819)   (94,069)   (588,373)
Other receivables   -    15,760    31,496    18,146    68,786    134,188 
                             2,285,870 

 

   US$   US$   US$   US$   US$   US$ 
   Trade and other receivables 
   Days past due 
  

Not past

due

  

1 – 60

days

  

61 – 120

days

   > 120 days   > 365 days  

 

Total

 
   US$   US$   US$   US$   US$   US$ 
                         
June 30, 2025                              
ECL rate   15%   54%   54%   59%   59%   - 
Estimated total gross carrying amount at   632,695    770,490    192,280    303,801    255,034    2,154,300 
ECL   

(91,560

)   

(136,811

)   

(53,479

)   

(106,784

)   

(73,959

)   

(462,593

)
Other receivables   -    

12,391

    

24,763

    

14,267

    

54,081

    

105,502

 
                             1,797,209 

 

   S$   S$   S$   S$   S$   S$ 
   Trade and other receivables 
   Days past due 
  

Not past

due

  

1 – 60

days

  

61 – 120

days

   > 120 days   > 365 days  

 

Total

 
   S$   S$   S$   S$   S$   S$ 
                         
June 30, 2025                              
ECL rate   15%   54%   54%   59%   59%   - 
Estimated total gross carrying amount at   804,724    979,987    244,561    386,405    324,378    2,740,055 
ECL   (116,455)   (174,010)   (68,020)   (135,819)   (94,069)   (588,373)
Other receivables   -    

15,760

    

31,496

    

18,146

    

68,786

    

134,188

 
                             2,285,870 
                               
June 30, 2024                              
ECL rate   1.95%   2.02%   2.61%   10.54%   89.08%     
Estimated total gross carrying amount at   814,544    321,783    227,123    323,323    446,800    2,133,573 
ECL   (15,880)   (6,494)   (5,939)   (34,093)   (398,007)   (460,413)
Other receivables   -    -    -    -    213,644    213,644 
                             1,886,804 
Schedule of remaining contractual undiscounted repayment obligations

The table below summarises the maturity profile of the Group’s financial assets and liabilities at the reporting date based on contractual undiscounted repayment obligations.

 

  

   Carrying amount   Contractual cash flows   One year or less   Two years to five years 
   US$   US$   US$   US$ 
December 31, 2025                    
Financial assets                    
Trade and other receivables   8,158,454    8,158,454    8,158,454    - 
Amount due from shareholder   1,062,684    1,062,684    1,062,684    - 
Amount due from third party   272,183    272,183    272,183    - 
Cash and cash equivalents   1,044,640    1,044,640    1,044,640    - 
Total undiscounted financial assets   10,537,961    10,537,961    10,537,961    - 

 

 

Basel Medical Group Ltd and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the financial period ended December 31, 2025

 

22. Financial risk management (Continued)

 

  c) Liquidity risk (Continued)

 

Analysis of financial instruments by remaining contractual maturities (Continued)

 

   Carrying amount   Contractual cash flows   One year or less   Two years to five years 
   US$   US$   US$   US$ 
December 31, 2025 -Continued                    
Financial liabilities                    
Trade and other payables   2,690,104    2,690,104    2,690,104    - 
Lease liabilities   4,702,129    4,869,009    1,687,392    3,181,617 
Amount due to related parties   690,384    690,384    690,384    - 
Borrowings   2,276,603    2,609,264    894,803    1,714,461 
Total undiscounted financial liabilities   10,359,220    10,858,761    5,962,683    4,896,078 
                     
Total net undiscounted financial assets   178,741    (320,800)   4,575,278    (4,896,078)

 

   Carrying amount   Contractual cash flows   One year or less   Two years to five years 
   S$   S$   S$   S$ 
December 31, 2025                    
Financial assets                    
Trade and other receivables   10,536,972    10,536,972    10,536,972    - 
Amount due from shareholder   1,366,505    1,366,505    1,366,505    - 
Amount due from third party   350,000    350,000    350,000    - 
Cash and cash equivalents   1,343,303    1,343,303    1,343,303    - 
Total undiscounted financial assets   13,596,780    13,596,780    13,596,780    - 
                     
Financial liabilities                    
Trade and other payables   3,674,814    3,674,814    3,674,814    - 
Lease liabilities   6,046,468    6,261,059    2,169,818    4,091,241 
Amount due to related parties   887,764    887,764    887,764    - 
Borrowings   2,927,484    3,355,253    1,150,627    2,204,626 
Total undiscounted financial liabilities   13,536,530    14,178,890    7,883,023    6,295,867 
                     
Total net undiscounted financial assets   (1,559,747)   (1,559,747)   5,713,757    (6,295,867)

 

 

Basel Medical Group Ltd and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the financial period ended December 31, 2025

 

22. Financial risk management (Continued)

 

  c) Liquidity risk (Continued)

 

Analysis of financial instruments by remaining contractual maturities (Continued)

 

   Carrying amount   Contractual cash flows   One year or less   Two years to five years 
   S$   S$   S$   S$ 
June 30, 2025 (Audited)                    
Financial assets                    
Trade and other receivables   8,924,312    8,924,312    8,924,312    - 
Cash and cash equivalents   3,044,466    3,044,466    3,044,466    - 
Total undiscounted financial assets   11,968,778    11,968,778    11,968,778    - 
                     
Financial liabilities                    
Trade and other payables   6,295,147    6,295,147    6,295,147    - 
Lease liabilities   5,016,475    5,244,654    2,210,787    3,033,867 
Amount due to related parties   1,450,305    1,450,305    1,450,305    - 
Borrowings   61,371    61,371    61,371    - 
Total undiscounted financial liabilities   12,823,298    13,051,477    10,017,610    3,033,867 
                     
Total net undiscounted financial assets/ -liabilities   (854,520)   (1,082,699)   1,951,168    (3,033,867)

The table below summarises the maturity profile of the Group’s financial assets and liabilities at the reporting date based on contractual undiscounted repayment obligations.

 

  

Carrying

amount

  

Contractual

cash flows

  

One year

or less

  

Two years

to five years

 
   US$   US$   US$   US$ 
June 30, 2025                    
Financial assets                    
Trade and other receivables   7,016,520    7,016,520    7,016,520    - 
Cash and cash equivalents   2,393,636    2,393,636    2,393,636    - 
Total undiscounted financial assets   9,410,156    9,410,156    9,410,156    - 

 

 

Basel Medical Group Ltd. and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

 

25.Financial risk management (Continued)

 

  c) Liquidity risk (Continued)

 

Analysis of financial instruments by remaining contractual maturities (Continued)

 

  

Carrying

amount

  

Contractual

cash flows

  

One year

or less

  

Two years

to five years

 
   US$   US$   US$   US$ 
June 30, 2025 (Continued)                    
Financial liabilities                    
Trade and other payables   4,949,404    4,949,404    4,949,404    - 
Lease liabilities   

3,944,080

    

4,123,479

    

1,738,177

    

2,385,303

 
Amount due to related parties   1,140,266    1,140,266    1,140,266    - 
Borrowings   

48,251

    

48,251

    48,251    

-

 
Total undiscounted financial liabilities   10,082,001    10,261,400    7,876,098    2,385,303 
                     
Total net undiscounted financial assets/ (liabilities)   (671,845)   (851,244)   1,534,058    (2,385,303)

 

  

Carrying

amount

  

Contractual

cash flows

  

One year

or less

  

Two years to

five years

 
   S$   S$   S$   S$ 
June 30, 2025                    
Financial assets                    
Trade and other receivables   8,924,312    8,924,312    8,924,312    - 
Cash and cash equivalents   3,044,466    3,044,466    3,044,466    - 
Total undiscounted financial assets   11,968,778    11,968,778    11,968,778    - 
                     
Financial liabilities                    
Trade and other payables   6,295,147    6,295,147    6,295,147    - 
Lease liabilities   

5,016,475

    

5,244,654

    

2,210,787

    

3,033,867

 
Amount due to related parties   1,450,305    1,450,305    1,450,305    - 
Borrowings   

61,371

    

61,371

    

61,371

    - 
Total undiscounted financial liabilities   12,823,298    13,051,477    10,017,610    3,033,867 
                     
Total net undiscounted financial assets/ (liabilities)   (854,520)   (1,082,699)   1,951,168    (3,033,867)

 

 

Basel Medical Group Ltd. and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

 

25.Financial risk management (Continued)

 

c)Liquidity risk (Continued)

 

Analysis of financial instruments by remaining contractual maturities (Continued)

 

  

Carrying

amount

  

Contractual

cash flows

  

One year

or less

  

Two years

to five years

 
   S$   S$   S$   S$ 
June 30, 2024                    
Financial assets                    
Trade and other receivables   1,763,412    1,763,412    1,763,412    - 
Cash and cash equivalents   1,951,053    1,951,053    1,951,053    - 
Amount due from related parties   10,557,240    10,557,240    10,557,240    - 
Total undiscounted financial assets   14,271,705    14,271,705    14,271,705    - 
                     
Financial liabilities                    
Trade and other payables   2,184,619    2,184,619    2,184,619    - 
Lease liabilities   28,500    29,000    29,000    - 
Amount due to related parties   1,311,390    1,311,390    1,311,390    - 
Amount due to a former director   111,459    111,459    111,459    - 
Borrowings   4,261,290    4,261,290    2,677,856    1,583,434 
Total undiscounted financial liabilities   7,897,258    7,897,758    6,314,324    1,583,434 
                     
Total net undiscounted financial assets/(liabilities)   6,374,447    6,373,947    7,957,381    (1,583,434)